Dr Oriaku Adaure Kas-osoka, MD | |
1524 Pinto Ln Fl 3, Las Vegas, NV 89106-4195 | |
(702) 944-2828 | |
(702) 944-2852 |
Full Name | Dr Oriaku Adaure Kas-osoka |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 1524 Pinto Ln Fl 3, Las Vegas, Nevada |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356664205 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 15694 (Nevada) | Primary |
2080A0000X | Pediatrics - Adolescent Medicine | 15694 (Nevada) | Secondary |
Entity Name | University Of Arkansas For Medical Sciences |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. announced today that they met with the U.S. Food and Drug Administration ("FDA") on September 2, 2009 to discuss the FDA's June 30, 2009 Complete Response Letter regarding the New Drug Application for Acurox (oxycodone HCl and niacin) Tablets CII (NDA).
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
For the first time in 25 years, rates of smoking among teenage boys in Ireland are increasing, according to a study published in ERJ Open Research.
MET protein levels correlate strongly with epithelial-mesenchymal transition phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.
Cardinal Health today announced plans to acquire Kinray, Inc., a leading pharmaceutical distributor serving the New York metropolitan area, for $1.3 billion in an all-cash transaction that will significantly expand its ability to serve retail independent pharmacies in the northeastern United States.
› Verified 5 days ago
Entity Name | Arkansas Childrens Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. announced today that they met with the U.S. Food and Drug Administration ("FDA") on September 2, 2009 to discuss the FDA's June 30, 2009 Complete Response Letter regarding the New Drug Application for Acurox (oxycodone HCl and niacin) Tablets CII (NDA).
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
For the first time in 25 years, rates of smoking among teenage boys in Ireland are increasing, according to a study published in ERJ Open Research.
MET protein levels correlate strongly with epithelial-mesenchymal transition phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.
Cardinal Health today announced plans to acquire Kinray, Inc., a leading pharmaceutical distributor serving the New York metropolitan area, for $1.3 billion in an all-cash transaction that will significantly expand its ability to serve retail independent pharmacies in the northeastern United States.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Oriaku Adaure Kas-osoka, MD 3016 W Charleston Blvd Ste 100, Las Vegas, NV 89102-1973 Ph: (702) 780-2311 | Dr Oriaku Adaure Kas-osoka, MD 1524 Pinto Ln Fl 3, Las Vegas, NV 89106-4195 Ph: (702) 944-2828 |
News Archive
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. announced today that they met with the U.S. Food and Drug Administration ("FDA") on September 2, 2009 to discuss the FDA's June 30, 2009 Complete Response Letter regarding the New Drug Application for Acurox (oxycodone HCl and niacin) Tablets CII (NDA).
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
For the first time in 25 years, rates of smoking among teenage boys in Ireland are increasing, according to a study published in ERJ Open Research.
MET protein levels correlate strongly with epithelial-mesenchymal transition phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.
Cardinal Health today announced plans to acquire Kinray, Inc., a leading pharmaceutical distributor serving the New York metropolitan area, for $1.3 billion in an all-cash transaction that will significantly expand its ability to serve retail independent pharmacies in the northeastern United States.
› Verified 5 days ago
Randi E Lampert, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2050 Mariner Dr, Suite #150, Las Vegas, NV 89128 Phone: 702-228-9066 | |
Sora Song, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3201 S Maryland Pkwy Ste 608, Las Vegas, NV 89109 Phone: 702-457-5437 Fax: 702-464-5801 | |
Dr. Noah Benjamin Kohn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1800 W. Charleston Blvd., Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 888-456-2467 | |
David Blank, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10105 Banburry Cross Dr, Suite 370, Las Vegas, NV 89144 Phone: 702-260-4525 Fax: 702-869-0133 | |
Vicki Hom, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4570 S. Eastern Ave, Suite #21, Las Vegas, NV 89119 Phone: 702-733-6033 Fax: 702-733-6033 | |
Ms. Elsa H Von Schulenburg, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4800 Alpine Pl, Suite 10, Las Vegas, NV 89107 Phone: 702-851-3572 Fax: 702-851-3574 | |
Ruben J Acherman, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3131 La Canada St Ste 230, Las Vegas, NV 89169 Phone: 702-732-1290 Fax: 702-732-1385 |